Search

everythinglearnresearchcommunity

for

Search:↓

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Combining microsurgery with craniofacial reconstruction improves aesthetic results and reduces harm to the area where tissue is taken from.

Good preoperative assessment is crucial for safe and effective eyelid and brow cosmetic surgery.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Type I interferons play a key role in the development of various skin diseases.

PRP therapy may improve skin and hair conditions, but more research with standard methods is needed.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

The document concludes that understanding the anatomical changes of the ageing face is important for effective rejuvenation treatments.

Eyelashes protect the eyes, but more research is needed to understand how.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Oral minoxidil 5 mg daily increases hair growth safely in men with hair loss, with minor side effects.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Older adults in Ottawa commonly have skin conditions like sun damage, dry skin, and hair loss.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Looking at skin can help find and treat serious diseases early.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

The superficial temporal artery flap is a reliable method for reconstructing complex facial defects with minimal complications.

Combining cosmetic procedures with lifestyle changes improves antiaging results.